EF
COLL icon

Empowered Funds’s Collegium Pharmaceutical COLL Stock Holding History

Empowered Funds’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Sell
56,504
-880
-2% -$30.1K 0.01% 1179
2026
Q1 		$1.9M Buy
57,384
+24,734
+76% +$1.05M 0.01% 1135
2025
Q4 		$1.51M Buy
+32,650
New +$1.37M 0.03% 566
2025
Q1 		– Sell
-16,575
Closed -$475K – 1649
2024
Q4 		$475K Sell
16,575
-104,871
-86% -$3.47M 0.01% 1201
2024
Q3 		$4.69M Buy
+121,446
New +$4.33M 0.07% 382

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Empowered Funds's COLL Position: Q2 2026 in Review

Empowered Funds reduced its Collegium Pharmaceutical (COLL) stake by 1.5% in Q2 2026, selling an estimated $30.1K and leaving 56,504 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #1179.

Empowered Funds first reported a position in COLL in Q3 2024 and has held it in 5 quarters since. The position peaked at $4.69M in Q3 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Empowered Funds held 56,504 shares of Collegium Pharmaceutical worth $2.05M as of Q2 2026.
  • Empowered Funds sold 880 Collegium Pharmaceutical shares in Q2 2026, an estimated $30.1K.
  • Collegium Pharmaceutical made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1179 holding.
  • Empowered Funds first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 5 quarters since.
  • Empowered Funds's Collegium Pharmaceutical position peaked at $4.69M in Q3 2024.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.